Pegylated interferon for recurrent hepatitis C in liver transplant recipients with renal failure: a prospective cohort study

Hepatitis C (HCV) universally recurs following orthotopic liver transplantation (OLT), representing an important cause for retransplantation. Although it is often treated with interferon and ribavirin, ribavirin is contraindicated in the presence of renal failure. In this setting of renal failure, p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2003-06, Vol.35 (4), p.1478-1479
Hauptverfasser:	Mukherjee, S, Gilroy, R.K, McCashland, T.M, Schafer, D.F
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - therapeutic use Biopsy Cohort Studies Female Genotype Hepacivirus - genetics Hepacivirus - isolation & purification Hepatitis C - drug therapy Hepatitis C - surgery Humans Immunosuppressive Agents - therapeutic use Interferon alpha-2 Interferon-alpha - therapeutic use Liver Transplantation - immunology Liver Transplantation - pathology Male Middle Aged Polyethylene Glycols - therapeutic use Recombinant Proteins Recurrence Renal Insufficiency - drug therapy Renal Insufficiency - virology Risk Assessment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!